Buzz Cup: Consuming Caffeine As You Get Older
October 18, 2023
Most would agree that there’s nothing like a good cup of coffee, especially to get you going in the morning. In fact, a recent survey of 2000 American coffee drinkers found that 81% of those surveyed said it’s that first cup of the day that motivates them to get out…
Medicare 101: Reviewing Basics To Prepare For The Upcoming Annual Enrollment Period
September 13, 2023
As you likely know, Medicare is a federal program that provides health insurance to older Americans. Most people think Medicare is incredibly complicated (and it is), but if you break it down into pieces, it’s easier to understand and plan for your needs. In our desire to help you better…
Hope For The Best: New Medications May Slow The Progress of Alzheimer’s- If You Can Access Them
May 17, 2023
For the more than 6 million Americans currently thought to have Alzheimer’s, and their loved ones, the possible benefits of new medications can’t come soon enough. As the most common cause of dementia, Alzheimer’s Disease predominantly afflicts older women (⅔ of Alzheimer’s patients are female) and almost ¾ of those…
Pins And Needles: Aging With Anxiety
March 15, 2023
There are probably lots of good reasons for you to feel anxious these days. Maybe you’re experiencing health problems. Maybe you’re worried about your family or even the future of our country. Maybe you’re concerned about inflation and the endurance of your retirement savings (or maybe even the safety of…
Sick At Heart: A New Option For Cutting Your Bad Cholesterol
March 8, 2023
The estimates are staggering: nearly 40 million American adults take a statin in order to lower their levels of LDL (bad) cholesterol, which can lead to blocked arteries and heart attacks if not kept under control. While a healthy lifestyle is also critical for keeping cardiac risk at bay, there’s…
Hope In A Bottle: Leqembi, The Newly Approved Alzheimer’s Medication
January 11, 2023
As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…